N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis

Библиографические подробности
Главные авторы:	Kasperzyk, J, d'Azzo, A, Platt, F, Seyfried, T
Формат:	Conference item
Опубликовано:	2004

Схожие документы

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
по: Kasperzyk, J, и др.
Опубликовано: (2004)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
по: Kasperzyk, J, и др.
Опубликовано: (2005)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
по: Baek, R, и др.
Опубликовано: (2008)

N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
по: Baek, R, и др.
Опубликовано: (2004)

Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
по: Kasperzyk, J, и др.
Опубликовано: (2005)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
по: Kasperzyk, J, и др.
Опубликовано: (2002)

Substrate reduction therapy reduces brain ganglioside GM2 in neonatal Sandhoff disease mice
по: Baek, R, и др.
Опубликовано: (2005)

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
по: Jeyakumar, M, и др.
Опубликовано: (2003)

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.
по: Elliot-Smith, E, и др.
Опубликовано: (2008)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
по: Ranes, M, и др.
Опубликовано: (2001)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
по: Pshezhetsky, A, и др.
Опубликовано: (2017)

Therapeutic assessment of substrate deprivation using NB-DGJ in GM1 storage disease mice
по: Seyfried, T, и др.
Опубликовано: (2003)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
по: Pshezhetsky, A, и др.
Опубликовано: (2017)

Altered expression of ganglioside metabolizing enzymes results in GM3 ganglioside accumulation in cerebellar cells of a mouse model of juvenile neuronal ceroid lipofuscinosis
по: Somogyi, A, и др.
Опубликовано: (2018)

GM1 ganglioside-independent intoxication by Cholera toxin
по: Cervin, J, и др.
Опубликовано: (2018)

Effects of substrate deprivation therapy on brain lipids in neonatal GML storage disease mice
по: Kasperzyk, J, и др.
Опубликовано: (2003)

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
по: Andersson, U, и др.
Опубликовано: (2004)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
по: Harlalka, G, и др.
Опубликовано: (2013)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
по: Andersson, U, и др.
Опубликовано: (2000)

New GM1 Ganglioside Derivatives for Selective Single and Double Labelling of the Natural Glycosphingolipid Skeleton
по: Polyakova, S, и др.
Опубликовано: (2009)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
по: Huebecker, M, и др.
Опубликовано: (2019)

Mef2C regulates the morphology of postnatal cerebellar Purkinje cells
по: Peh, Wei Jie
Опубликовано: (2017)

Changes in TRPC channel expression during postnatal development of cerebellar neurons.
по: Huang, W, и др.
Опубликовано: (2007)

Ganglioside antibodies and neuropathies.
по: Rinaldi, S, и др.
Опубликовано: (2008)

Phenotyping of nNOS neurons in the postnatal and adult female mouse hypothalamus
по: Chachlaki, K, и др.
Опубликовано: (2017)

Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
по: Denny, C, и др.
Опубликовано: (2010)

Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation
по: Tech, Katherine, и др.
Опубликовано: (2018)

Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides
по: Pan, X, и др.
Опубликовано: (2017)

Heat shock protein amplification improves cerebellar myelination in the Npc1nih mouse model
по: Gray, J, и др.
Опубликовано: (2022)

Sexual dimorphism of microglia and synapses during mouse postnatal development
по: Weinhard, L, и др.
Опубликовано: (2018)

Lysosomal storage diseases
по: Platt, F, и др.
Опубликовано: (2018)

Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders
по: Mitoma, H., и др.
Опубликовано: (2021)

Framing genetically modified (GM) food: a content analysis of GM food coverage in the New York Times, Le Monde and the Straits Times (1992-2001).
по: Chan, Royston Chow Yang., и др.
Опубликовано: (2008)

The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia.
по: Becker, E
Опубликовано: (2014)

A transcriptomic atlas of mouse cerebellar cortex comprehensively defines cell types
по: Kozareva, Velina, и др.
Опубликовано: (2023)

Saturn, The GM/UAW Partnership
по: Rubinstein, Saul, и др.
Опубликовано: (2002)

STRONGLY SPECTRAL GM-SPACES
по: Edwards, C
Опубликовано: (1977)

Linear control system analysis and design : conventional and modern/
по: D'Azzo, John Joachim, и др.
Опубликовано: (1975)

Linear control system analysis and design : conventional and modern/
по: D'Azzo, John Joachim, и др.
Опубликовано: (1988)

Feedback control system analysis and synthesis/
по: D'Azzo, John Joachim, и др.
Опубликовано: (1966)